Innovations in CNS: Novel therapeutics and future RandD strategies

The CNS drug market presents significant profit opportunities, but also carries high risks for companies aiming to achieve blockbuster status.

Pipelines based on novel molecular targets to treat underlying disease promise to transform the treatment of psychiatric and neurological diseases, however research and development of these drugs requires an innovative approach to ensure investment is maximized.

Read more...

• Obesity Drug Markets (14/10/2008)
• The Anti-Infectives Market Outlook to 2013 (14/10/2008)
• Respiratory Disorders (14/10/2008)

• Multiple Myeloma (16/05/2008)
• Innovation in Drug Delivery (15/05/2008)
• Next-Generation Nutraceuticals (15/05/2008)

• Protein Engineering & Drug Design (14/05/2008)
• Winning Product Launch Strategies (14/05/2008)
• Drug Repositioning Strategies (14/05/2008)
• Outlook for RNAi (14/05/2008)
• Targeted Cancer Therapies (14/05/2008)
• The Future of Biosimilars (14/05/2008)
• Cardiovascular Disease Management (14/05/2008)
• Nanotechnology (12/05/2008)
• The Future of Targeted Therapeutics (12/05/2008)

---